Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Price Hits Forecast Target with 31.69% Profit

May 03, 2023
ELI LILLY AND COMPANY stock recently hit the forecast target set by QuantWave, resulting in a profit of 31.69% for investors. The forecast signal was issued on July 8, 2022, with the stock price at $321.95 and a predicted long direction. On May 3, 2023, the stock reached $423.98, achieving the target price.

This successful forecast for ELI LILLY AND COMPANY demonstrates the accuracy and effectiveness of QuantWave's analytics. The market analysis and factors contributing to this stock movement suggest a strong performance by the company, possibly due to positive financial results, industry trends, or other specific catalysts.

QuantWave's automated forecasting platform provides users with predictions for various stocks, offering lucrative opportunities for potential profits. For those interested in a more in-depth understanding of the investment strategy, QuantSchool offers valuable educational resources outlining the key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

CMEMarch 10, 2025QuantWave Achieves 15.8% Profit Target Forecast for CME GROUP INC.  ~1 min.

QuantWave, the automated forecasting platform, successfully reached its price target forecast for CME GROUP INC., generating a profit of 15.8%....

NVDAMay 25, 2023QuantWave Achieves 34.63% Profit Target Forecast for NVIDIA CORPORATION  ~2 min.

QuantWave, the automated forecasting platform, recently celebrated a significant achievement as it successfully hit the price target forecast for NVIDIA CORPORATION, resulting in a profit of 34.63%....

FIL-USDApril 8, 2025FILECOIN USD Hits 30.31% Profit Target Success Following QuantWave Forecast  ~1 min.

On February 28, 2025, QuantWave issued a short signal for FILECOIN USD with a price of 3.25 $. The automated forecasting platform accurately predicted a downward movement in the stock price....

ALBApril 8, 2025ALBEMARLE CORPORATION Hits Short Price Target Forecast with 29.76% Profit  ~1 min.

ALBEMARLE CORPORATION has successfully achieved the price target forecast set by QuantWave, with a significant profit margin of 29.76%....

VMCFebruary 27, 2025Profit Achievement: Vulcan Materials Company Hits Price Target with 7.26% Gain  ~1 min.

QuantWave's forecast for Vulcan Materials Company, with a signal date of December 24, 2024, has successfully reached its price target on February 27, 2025....